{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:41Z","timestamp":1767134801000,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001720","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,7,19]],"date-time":"2004-07-19T00:00:00Z","timestamp":1090195200000}}],"reference-count":87,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001720.pub2","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T03:09:48Z","timestamp":1097723388000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Depot pipotiazine palmitate and undecylenate for schizophrenia"],"prefix":"10.1002","volume":"2009","author":[{"given":"Mohandas","family":"Dinesh","sequence":"first","affiliation":[{"name":"Leeds Community Mental health Teaching NHS Trust; Psychiatry; Department of Liaison Psychiatry, Becklin centre Alma Street Leeds W Yorkshire UK LS9 7BE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry; De Crespigny Park BOX PO68 London UK SE5 8AF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema N","family":"Quraishi","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry; De Crespigny Park BOX PO68 London UK SE5 8AF"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,19]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0001|cit1","first-page":"897","article-title":"Long term double-blind evaluation of pipotiazine palmitate and fluphenazine decanoate","volume":"27","author":"Albert","year":"1980","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0002|cit2","first-page":"662","article-title":"A double-blind trial of haloperidol decanoate and pipothiazine palmitate in the maintenance treatment of schizophrenics in a public out-patient clinic","volume":"37","author":"Bechelli","year":"1985","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD001720.pub2-BIB0003|cit3","first-page":"121","article-title":"Short term double blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia","volume":"12","author":"Bechelli","year":"1986","journal-title":"Encephale"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0004|cit4","first-page":"218","article-title":"A comparison trial of pipotiazine palmitate, haloperidol decanoate and flupenthixol decanoate in treatment of schizophrenic patients","volume":"31","author":"Chai","year":"1998","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0005|cit5","first-page":"148","article-title":"A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients","volume":"Feb-Mar","author":"Chouinard","year":"1978","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0447.1973.tb07048.x","article-title":"A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes","volume":"suppl 241","author":"Dencker","year":"1973","journal-title":"Acta Psychiatrica Scandanavica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0447.1978.tb06879.x","article-title":"How schizophrenic patients change during 3 years' treatment with depot neuroleptics","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0447.1978.tb06878.x","article-title":"Three years' maintenance neuroleptic treatment in schizophrenia - before and beyond","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatrica Scandanavica"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0009|cit9","first-page":"585","article-title":"A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrneic patients","volume":"18","author":"Jain","year":"1975","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0010|cit10","first-page":"536","article-title":"A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia","volume":"30","author":"Leong","year":"1989","journal-title":"Singapore Medical Journal"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0447.1973.tb07046.x","article-title":"Pipothiazine palmitate in the long-term treatment of chronic psychoses. A controlled trial on in-patients","volume":"244","author":"Robak","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD001720.pub2-BIB0012|cit12","first-page":"642","article-title":"A comparative controlled study of two long-acting phenothiazines: pipothiazine palmitate and fluphenazine decanoate","volume":"23","author":"Schlosberg","year":"1978","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1019579","article-title":"Cinical blood chemistry values and long acting phenothiazines","volume":"14","author":"Schneider","year":"1981","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1978.01770310099008","article-title":"Standard and long-acting depot neuroleptics in chronic schizophrenics","volume":"35","author":"Simon","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001720.pub2-BIB0015|cit15","first-page":"121","article-title":"A comparative study of prolonged action (depot) neuroleptics: pipotiazine palmitate versus fluphenazine enanthate in chronic schizophrenic patients","volume":"25","author":"Singh","year":"1979","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/030006058601400204","article-title":"A comparative trial of depot pipothiazine","volume":"14","author":"Steinert","year":"1986","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0017|cit17","first-page":"117","article-title":"Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics","volume":"75","author":"Veerecken","year":"1972","journal-title":"Psychiatria, Neurologia, Neurochirurgia"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000468309","article-title":"Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial","volume":"12","author":"Woggon","year":"1977","journal-title":"International Pharmacopsychiatria"},{"issue":"3","key":"10.1002\/14651858.CD001720.pub2-BIB0019|cit19","first-page":"137","article-title":"Double-blind controlled study in the effect of pipotiazine palmitate and fluphenazine decanoate in the treatment of schizophrenia","volume":"26","author":"Song","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0020|cit20","unstructured":"Ahlfors UG A double-blind trial with long-acting neuroleptics (Abstract number 340) V World Congress of Psychiatry Ciudad de Mexico"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1973.tb07047.x","article-title":"Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine decanoate","volume":"supp 241","author":"Ahlfors","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0022|cit22","first-page":"267","article-title":"Drug Research","volume":"25","author":"Angst","year":"1975","journal-title":"Arzneim-Forsch"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/030006058000800409","article-title":"Pipothiazine palmitate in the long-term treatment of schizophrenia","volume":"8","author":"Aref","year":"1980","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD001720.pub2-BIB0024|cit24","first-page":"309","article-title":"Clinical experience with the neuroleptic 19366 RP (pipothiazine)","volume":"6","author":"Arrojo Lois","year":"1978","journal-title":"Actas Luso Espanolas de Neurologia Psiquiatria y Ciencias Afines"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0447.1974.tb09710.x","article-title":"A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics","volume":"50","author":"Astrup","year":"1974","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0026|cit26","first-page":"116","article-title":"A comparison of the efficacy of fluphenazine decanoate and hydroxyprotepine decanoate in the treatment of schizophrenia (a double-blind crossover study)","volume":"82","author":"Balon","year":"1982","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0027|cit27","first-page":"305","article-title":"A double blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients.","volume":"16","author":"Bechelli","year":"1983","journal-title":"Brazilizn Journal of Medical and Biological Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0028|cit28","unstructured":"Deberdt R Luyssaert W Le traitement de psychoses delirantes chroniques par la pipothiazine (19.366 RP) et l'ester palmitique de pipothiazine (19.55 RP) 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico 1971 93097267"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0029|cit29","first-page":"7","article-title":"A double-blind trial of fluspirilene versus flupenthixol decanoate in the treatment of schizophrenic inpatients","volume":"15","author":"Demerdash","year":"1981","journal-title":"Journal of The Kuwait Medical Association"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0447.1980.tb07080.x","article-title":"Clopentixol and flupenthixol depot preparations in outpatients schzophrenics. 1. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate","volume":"279","author":"Dencker","year":"1980","journal-title":"Acta Psychatrica Scandinavica Supplementum"},{"issue":"5","key":"10.1002\/14651858.CD001720.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-0447.1973.tb04447.x","article-title":"Dexetimide:an effective drug for the control of extrapyramidal symptoms induced by pipthiazine palmitate","volume":"49","author":"Dom","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD001720.pub2-BIB0032|cit32","first-page":"167","article-title":"The depot compounds moditen (fluphenazine) and IMAP (flusipirilene) in clinical practice","volume":"16","author":"Faltus","year":"1974","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000468199","article-title":"The problem of post-psychotic schizophrenic depressions and their pharmacological induction","volume":"10","author":"Floru","year":"1975","journal-title":"International Pharmacopsychiatria"},{"issue":"1","key":"10.1002\/14651858.CD001720.pub2-BIB0034|cit34","first-page":"11","article-title":"Potential value of penfluridol and pipothiazine palmitate","volume":"11","author":"Gallant","year":"1975","journal-title":"Psychopharmacological Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0035|cit35","first-page":"689","article-title":"Pipothiazine palmitate, a long-acting neuroleptic: clinical and computerized EEG effects","volume":"24","author":"Itil","year":"1978","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02316862","article-title":"Perphenazine decanoate and cis(z)-flupenthixol decanoate in maintenance treatment of schizophrenic outpatients","volume":"105","author":"Kistrup","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02316862","article-title":"Perphenazine decanoate and cis(z)-flupenthixol decanoate in maintenance treatment of schizophrenic outpatients","volume":"105","author":"Kistrup","year":"1991","journal-title":"Psychopharmacology"},{"issue":"supp 322","key":"10.1002\/14651858.CD001720.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1985.tb08538.x","article-title":"Long-term depot neuroleptic treatment with perphenazine decanoate I","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"supp 322","key":"10.1002\/14651858.CD001720.pub2-BIB0039|cit39","first-page":"40","article-title":"Long-term depot neuroleptic treatment with perphenazine decanoate II","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"supp 322","key":"10.1002\/14651858.CD001720.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1985.tb08536.x","article-title":"Perphenazine decanoate in sesame oil vs perphenazine enanthate in sesame oil","volume":"76","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000407841","article-title":"AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics","volume":"20","author":"Lapierre","year":"1983","journal-title":"Modern problems of Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001720.pub2-BIB0042|cit42","first-page":"17","article-title":"Indications and results in the use of 19.552RP","volume":"30","author":"Lopez Ibor Alino","year":"1971","journal-title":"Actas Luso Espanolas de Neurologia y Psiquiatria"},{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0043|cit43","first-page":"655","article-title":"Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)","volume":"10","author":"Masiak","year":"1976","journal-title":"Psychiatria Polska"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0044|cit44","first-page":"421","article-title":"Pipothiazine (piportil) in the treatment of various forms of schizophrenia","volume":"13","author":"Matkowski","year":"1979","journal-title":"Psychiatria Polska"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-3956(93)90059-B","article-title":"Intermittent versus maintenance neuroleptic long-term treatment in schizophrenia -2 year results of a german multicenter study","volume":"27","author":"Pietzcker","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0046|cit46","unstructured":"Rojo- Sierra Alonso J Diez E Giner J Loret E 5th World Congress of Psychiatry 1971 495 6"},{"issue":"2","key":"10.1002\/14651858.CD001720.pub2-BIB0047|cit47","first-page":"259","article-title":"Problems posed by trial use of prolonged action neuroleptics in acute psychiatric syndromes","volume":"1","author":"Ropert","year":"1973","journal-title":"Annales Medico Psychologiques"},{"issue":"4","key":"10.1002\/14651858.CD001720.pub2-BIB0048|cit48","first-page":"227","article-title":"Experience with perphenazine-enanthate in the maintenance therapy of schizophrenic psychoses","volume":"24","author":"Rysanek","year":"1982","journal-title":"Activitas Nervosa Superior (Praha)"},{"issue":"9-12;1-8","key":"10.1002\/14651858.CD001720.pub2-BIB0049|cit49","first-page":"10","article-title":"Clinical experience with pipothiazine palmitate (19552 RP) in hospitalized and open ward patients with functional psychoses","volume":"not known","author":"Salvesen","year":"1974","journal-title":"Physicians Drug Manual"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0447.1972.tb04372.x","article-title":"Fluspirilene, an injectable and penfluridol, an oral long-acting neuroleptic","volume":"48","author":"Tanghe","year":"1972","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/08039489409078159","article-title":"A 3-year study of maintenance therapy with depot neuroleptics","volume":"48","author":"Tuninger","year":"1994","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0052|cit52","first-page":"45","article-title":"Fluspirilene (IMAP) administered in a bi-weekly dose for the prevention of relapses in chronic schizophrenics","volume":"79","author":"Vranckx-Haenen","year":"1979","journal-title":"Acta Psychiatrica Belgica"},{"issue":"2","key":"10.1002\/14651858.CD001720.pub2-BIB0053|cit53","first-page":"64","article-title":"Use of haloperidol decanoate in psychiatric diseases","volume":"40","author":"Zonda","year":"1992","journal-title":"Therapia Hungarica"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0054|cit54","unstructured":"Aaes-Jorgenson A Pharmacokinetics of oral and depot neuroleptics - clinical relevance Symposium Espo"},{"issue":"Issue 1","key":"10.1002\/14651858.CD001720.pub2-BIB0055|cit55","article-title":"Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]","author":"Alderson","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia","volume":"39","author":"Andreasen","year":"1983","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2165\/00002018-199410060-00005","article-title":"Long term depot antipsychotics. A risk benefit assessment","volume":"10","author":"Barnes","year":"1994","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/070674376701200608","article-title":"Medication antiparkinsonienne et bilan extrapyramidal: 'etude du trihexyphenidyl","volume":"12","author":"Bordeleau","year":"1967","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0061|cit61","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.146.5.464","article-title":"Long-term depot maintenance of chronic schizophrenic out-patients: the seven-year follow-up of the medical research council fluphenazine\/ placebo trial","volume":"146","author":"Curson","year":"1985","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0063|cit63","volume-title":"The neuropsychology of schizophrenia","author":"David","year":"1994"},{"issue":"suppl 1","key":"10.1002\/14651858.CD001720.pub2-BIB0064|cit64","first-page":"2","article-title":"The natural course of schizophrenia and effective maintenance drug therapy","volume":"6","author":"Davis","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"supp 279","key":"10.1002\/14651858.CD001720.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0447.1980.tb07084.x","article-title":"Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study","volume":"61","author":"Dencker","year":"1980","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD001720.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0067|cit67","volume-title":"Burdens of disease: a discussion document","author":"Department of Health","year":"1996"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"876-83 876-83","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0071|cit71","article-title":"Dosage Record and Treatment Emergent Symptoms Scale","volume-title":"National Institute of Mental Health","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0073|cit73","volume-title":"Compliance in health care","author":"Haynes","year":"1979"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo controlled trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia","volume":"21","author":"Honigfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0264180100000904","article-title":"Schizophrenia: manifestations, incidence and course indifferent cultures. A World Health Organization ten-country study","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine (Monograph Supplement)"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia","volume":"8","author":"Kane","year":"1998","journal-title":"European Neuropschopharmacology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0083|cit83","first-page":"364","article-title":"Anxiolytics sedatives, hypnotics and neuroleptics","volume-title":"Martindale: the extra pharmacopoeia","author":"Reynolds","year":"1993"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1994.03520020051014","article-title":"Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals","volume":"272","author":"Schulz","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0895-4356(94)00141-C","article-title":"Cost-effectiveness comparisons using \"real world\" randomized trials: the case of new antidepressant drugs","volume":"48","author":"Simon","year":"1995","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001720.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD001720.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001720.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:46:28Z","timestamp":1766691988000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001720.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,7,19]]},"references-count":87,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001720.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,19]]}}}